| BMS-1001 |
BMS-1001 |
2113650-04-5 |
| 1H-Benzimidazole-6-carboxylic acid, 2-[1-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinyl]-, methyl ester |
METHYL 2-(1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDIN-4-YL)-1H-BENZO[D]IMIDAZOLE-6-CARBOXYLATE |
2097938-51-5 |
| (2R)-2-({[3,5-bis(trifluoromethyl)phenyl]carbamothioyl}amino)-N-(2,4-difluorophenyl)-2-phenylacetamide |
BL 918 NEW |
2101517-69-3 |
| CSF1R-IN-1 |
CSF1R-IN-1 |
2095849-04-8 |
| SR-18292 |
2095432-55-4 |
2095432-55-4 |
| A1874 |
A-1874;A 1874 |
2064292-12-0 |
| ADH-503 |
ADH-503;ADH503;ADH 503 |
2055362-74-6 |
| E3 Ligand-Linker Conjugate 7 |
E3 Ligand-Linker Conjugate 7 |
2022182-59-6 |
| CCG-1423 |
CCG1423 |
285986-88-1 |
| H-MET-ALA-GLY-PRO-HIS-PRO-VAL-ILE-VAL-ILE-THR-GLY-PRO-HIS-GLU-GLU-OH |
NFAT INHIBITOR |
249537-73-3 |
| 4-AMINO-1-TERT-BUTYL-3-(1'-NAPHTHYL)PYRAZOLO[3,4-D]PYRIMIDINE |
4 -氨基- 1 -叔丁基- 3 -(1' -萘基)吡唑并[3,4 - D]嘧啶 |
221243-82-9 |
| 1 NM-PP1 |
4-氨基1-叔丁基-3-(1'-萘甲基)吡唑并[3,4-D]嘧啶 |
221244-14-0 |
| MPEP HYDROCHLORIDE |
2-甲基-6-(苯基乙炔基)吡啶盐酸盐 |
219911-35-0 |
| 5,5'-(2,5-FURANDIYL)BIS-2-THIOPHENEMETHANOL |
5,5'-(2,5-呋喃二基)二-2-噻吩甲醇 |
213261-59-7 |
| SR-9243 |
N-[2-(3-溴苯基)乙基]-2,4,6-三甲基-N-[[3'-(甲基磺酰基)[1,1'-联苯]-4-基]甲基]苯磺酰胺 |
1613028-81-1 |
| BLU 9931 |
BLU 9931 |
1538604-68-0 |
| UNC 1999 |
UNC1999 |
1431612-23-5 |
| ML216 |
N-[4-氟-3-(三氟甲基)苯基]-N'-[5-(4-吡啶基)-1,3,4-噻二唑-2-基]脲 |
1430213-30-1 |
| NMS 873 |
NMS873 |
1418013-75-8 |
| N-[4-[(4-Chlorophenyl)Methoxy]-2-pyridinyl]-2,6-difluoro-benzeneacetaMide |
1415834-63-7 |
1415834-63-7 |
QQ
微信
